<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Creso Pharma Ltd’s wholly-owned Canadian subsidiary Mernova Medicinal Inc’s initial testing of cannabinoid content for four of its new cannabis strains have indicated that each new strain has shown a high level of THC content. This is a major achievement as it exceeds the industry average and is another key competitive advantage, underpinning Mernova’s potential expansion into new provinces and sales growth.
...read full article on Proactive Investors
